Wellstat Therapeutics   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Gaithersburg MD United States (1985)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2001
NCT00024427
First Marketed Drug
2015
uridine
First NDA Approval
2015
uridine
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

WELLSTAT THERAP | Wellstat Therapeutics Corporation